Skip to content

Functional Magnetic Resonance Imagine(fMRI)Navigation in Intracranial Arteriovenous Malformation Surgery

Blood Oxygen Level Dependent fMRI Navigation for Function Protection in Intracranial Arteriovenous Malformation Surgery: a Multicenter Prospective Randomized Controlled Single Blind Clinical Trial

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01758211
Acronym
FMRINAVMS
Enrollment
600
Registered
2013-01-01
Start date
2013-01-31
Completion date
2015-06-30
Last updated
2013-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Arteriovenous Malformations

Keywords

Intracranial Arteriovenous Malformations, Functional Magnetic Resonance Imaging, Neuronavigation

Brief summary

Little is known about the effect of fMRI navigation in the intracranial arteriovenous malformation surgery. The investigators aim to perform a multicenter prospective randomized single -blind clinical trial to assess the effect and safety of fMRI navigation in the brain arteriovenous malformation surgery.

Detailed description

Intracranial arteriovenous malformations (AVMs) are congenital lesions that consist of multiple arteries and veins, connecting as a fistula without an intervening normal capillary bed. Surgical removal is thought as a major treatment option for AVMs. However, compared with stereotaxic radiosurgery and endovascular embolization, microsurgery of AVMs is regarded with high mortality and morbidity, particular for high level classification AVMs . Blood oxygen level dependent fMRI can be used to mapping the motor and language regions of the brain noninvasively. It has been one of the most advanced functional imaging techniques and it has quickly grown to be a vital tool for clinical and cognitive neuroscience research. Many clinical researches have been reported about the utility of fMRI in brain tumor surgery. However, the effect of fMRI navigation for neurofunction protection in the intracranial arteriovenous malformation surgery was unclear. We aim to perform a multicenter prospective randomized single -blind clinical trial to assess the safety and effect of fMRI navigation in the intracranial AVMs surgery. We hypothesize that application of blood oxygen level dependent fMRI is able to improve long term prognosis of patients.

Interventions

PROCEDUREfMRI Navigation AVM resection

intraoperative fMRI navigation guided resection in AVM patients

conventional resection in AVM patients

Sponsors

Beijing Tiantan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
12 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosis of intracranial AVM by DSA/CT/MRI 2. Age from 12-60 years 3. Be suitable for microsurgery treatment 4. All patients are able to cooperate with the fMRI examination 5. All patients gave written informed consent

Exclusion criteria

1. Patients with age \< 12 years or \> 60 years 2. Various conditions unable to meet the indications for microsurgery treatment 3. Intracranial hemorrhage need emergency surgery 4. Patients can not cooperate with fMRI examination

Design outcomes

Primary

MeasureTime frameDescription
modified Ranking Scalesix months after operationThe scale runs from 0-6, running from perfect health without symptoms to death. 0-No symptoms. 1. No significant disability. Able to carry out all usual activities, despite some symptoms. 2. Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. Moderate disability. Requires some help, but able to walk unassisted. 4. Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. Dead.

Secondary

MeasureTime frameDescription
Postoperative complicationssix months after operationPost operative epilepsy seizure, hemorrhage,infarction.

Countries

China

Contacts

Primary ContactYong Cao, MD
caoyong6@hotmail.com861067096510

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026